https://www.selleckchem.com/pr....oducts/pha-767491.ht
Finally, no reproducible decline of RCI, defined as a decrease of 50%, was observed. AGS-004 and VOR were safe and well-tolerated, but no substantial impact on RCI was measured. In contrast to previous clinical data, AGS-004 did not induce HIV-specific immune responses greater than those measured at baseline. More efficacious antiviral immune interventions, perhaps paired with more effective latency reversal, must be developed to clear persistent HIV infection.An important sustainable development goal for any country is to ensure
Like
Comment
Share
